Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(11):811; doi:10.1093/jnci/96.11.811-c
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Japanese Translation
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content

© 2004 Oxford University Press

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Carcinogen Exposure and Reduced Carcinogen Tobacco

Although tobacco products with reportedly reduced carcinogen content are being marketed, carcinogen uptake in people who use these products compared with that in people using medicinal nicotine has not been assessed systematically. In a randomized study, Hatsukami et al. (p. 844) compared carcinogen uptake in users of smokeless tobacco who switched to Swedish snus or cigarette smokers who switched to OMNI cigarettes with that of men who quit and used the nicotine patch. The authors found that metabolite levels of a tobacco-specific carcinogen were much lower in men . . . [Full Text of this Article]

Comparing Lung Cancer Rates of Men and Women

Testing for an Immune Response in Prostate Cancer

Exclusive Pipe Smoking and Mortality

Short Hairpin RNA and Gene Silencing